- Clone
- 16A (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Mucin-1, MUC-1, Episialin, HMFG antigen, MAM6
- Isotype
- Mouse IgG1, λ
- Barcode Sequence
- CCGAATAATTTCAGC
Cat # | Size | Price | Quantity Check Availability | ||
---|---|---|---|---|---|
355623 | 10 µg | $369.00 |
Mucin-1 (MUC-1), cell surface associated or polymorphic epithelia mucin, is a 500-1000 kD proteoglycan expressed by activated T cells, mucosal epithelial cells, and aberrantly expressed on most breast cancers. In normal cells, CD227 is heavily glycosylated, whereas in cancerous cells, the glycosylation is incomplete and premature sialation is also observed. The protein is anchored to the apical surface of the epithelial cell and functions as a lubricant to keep the cell hydrated and to protect against pathogens. It can also function as a signaling molecule by forming a MUC-1/SOS1/GrB2 complex. MUC-1 can interact with cancer antigens such as Her2/neu.
Product Details
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Jurkat cells transfected with MUC1
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
- Preparation
- The antibody was purified by chromatography and conjugated with TotalSeq™-Bn oligomer under optimal conditions.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
- Application
-
SB - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining in formalin-fixed, paraffin-embedded (FFPE) lymphoid tissue, and the oligomer sequence is confirmed by sequencing. TotalSeq™-Bn antibodies are compatible with the 10x Visium CytAssist Gene and Protein Expression Assay.
To maximize performance, it is strongly recommended that the reagent be titrated for each application, and that you centrifuge the antibody dilution at 14,000xg at 2 − 8°C for 10 minutes before use. Carefully pipette out the liquid avoiding the bottom of the tube when handling. To determine and optimize dilutions for the addition of Totalseq™-Bn antibodies into pre-designed antibody panels, refer to 10x Genomics Custom Add-on Antibody Optimization guide.
Buyer is solely responsible for determining whether Buyer has all intellectual property rights that are necessary for Buyer's intended uses of the BioLegend TotalSeq™ products. For example, for any technology platform Buyer uses with TotalSeq™, it is Buyer's sole responsibility to determine whether it has all necessary third party intellectual property rights to use that platform and TotalSeq™ with that platform. - Application Notes
-
This clone shows stronger binding to the glycosylated compared to the non-glycosylated peptide1.
- Additional Product Notes
-
TotalSeq™-Bn reagents are designed to profile protein levels following an optimized protocol in spatial transcriptomics. Compatible spatial biology devices (e.g. Imaging System, 10x Genomics Visium Spatial CytAssist Gene and Protein Expression instruments and reagents) and sequencer (e.g. Illumina analyzers) are required. TotalSeq™-B reagents are not compatible with the 10x Genomics Visium system. The complete barcode sequence may be provided upon request. Please contact technical support for more information, or visit TotalSeq™-Bn Reagents for 10x Genomics Visium CytAssist Gene and Protein Assay.
-
Application References
(PubMed link indicates BioLegend citation) -
- Song W, et al. 2012. Int. J Oncol. 41:1977. PubMed
- RRID
-
AB_3097315 (BioLegend Cat. No. 355623)
Antigen Details
- Structure
- 500-1000 kD proteoglycan (glycosylated form)
- Distribution
-
Activated T cells, mucosal epithelial cells, aberrantly expressed in most breast cancers
- Interaction
- Complexes with SOS1 and Grb2 in RAS signaling
- Ligand/Receptor
- ICAM-1 and Her2/neu (ErbB2)
- Cell Type
- Dendritic cells, Epithelial cells, T cells
- Biology Area
- Immunology, Innate Immunity
- Molecular Family
- CD Molecules
- Antigen References
-
1. Gendler SJ. 2001. J. Mammary Gland Biol. Neoplasia. 6:339.
2. Agrawal B, et al. 1998. Cancer Res. 58:4079.
3. Rahn JJ, et al. 2004. J. Biol. Chem. 279:29386. - Gene ID
- 4582 View all products for this Gene ID
- UniProt
- View information about CD227 on UniProt.org
Other Formats
View All CD227 Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
PE anti-human CD227 (MUC-1) | 16A | FC |
Purified anti-human CD227 (MUC-1) | 16A | FC,ICC,IHC-P |
PE/Cyanine7 anti-human CD227 (MUC-1) | 16A | FC |
APC anti-human CD227 (MUC-1) | 16A | FC |
TotalSeq™-D1250 anti-human CD227 (MUC-1) | 16A | PG |
TotalSeq™-A1250 anti-human CD227 (MUC-1) | 16A | PG |
TotalSeq™-B1250 anti-human CD227 (MUC-1) | 16A | PG |
Brilliant Violet 421™ anti-human CD227 (MUC-1) | 16A | FC |
Brilliant Violet 711™ anti-human CD227 (MUC-1) | 16A | FC |
Brilliant Violet 785™ anti-human CD227 (MUC-1) | 16A | FC |
TotalSeq™-C1250 anti-human CD227 (MUC-1) | 16A | PG |
TotalSeq™-Bn1250 anti-human CD227 (MUC-1) | 16A | SB |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
PE anti-human CD227 (MUC-1)
-
Purified anti-human CD227 (MUC-1)
-
PE/Cyanine7 anti-human CD227 (MUC-1)
-
APC anti-human CD227 (MUC-1)
-
TotalSeq™-D1250 anti-human CD227 (MUC-1)
-
TotalSeq™-A1250 anti-human CD227 (MUC-1)
-
TotalSeq™-B1250 anti-human CD227 (MUC-1)
-
Brilliant Violet 421™ anti-human CD227 (MUC-1)
-
Brilliant Violet 711™ anti-human CD227 (MUC-1)
-
Brilliant Violet 785™ anti-human CD227 (MUC-1)
-
TotalSeq™-C1250 anti-human CD227 (MUC-1)
-
TotalSeq™-Bn1250 anti-human CD227 (MUC-1)